Oligonucleotide-mediated gene repair at DNA level: The potential applications for gene therapy

Journal of Molecular Medicine

Volumn 80, Issue 10, 2002, Pages 620-628

  Liu, Chang Mei ^a   Liu, De Pei ^a   Liang, Chih Chuan ^a  

^a INSTITUTE OF BASIC MEDICAL SCIENCES   (China)

Author keywords

Chimera; Gene therapy; Oligonucleotide; Review; Triplex

Indexed keywords

DNA; NUCLEOTIDE DERIVATIVE; OLIGODEOXYNUCLEOTIDE; OLIGONUCLEOTIDE; RNA;

CHIMERA; CHROMOSOME; DNA REPAIR; GENE MUTATION; GENE SEQUENCE; GENE THERAPY; GENETIC DISORDER; HUMAN; NONHUMAN; PROTEIN STRUCTURE; REVIEW; SITE DIRECTED MUTAGENESIS; SOUTHERN BLOTTING; TRIPLE HELIX; ANIMAL; CHEMISTRY; DRUG EFFECT; FORECASTING; GENETIC ENGINEERING; GENETICS; METABOLISM; METHODOLOGY;

ANIMALS; CHIMERA; DNA; DNA REPAIR; FORECASTING; GENE THERAPY; GENETIC ENGINEERING; HUMANS; MUTAGENESIS, SITE-DIRECTED; OLIGONUCLEOTIDES; RNA;

EID: 0036460772     PISSN: 09462716     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00109-002-0366-y     Document Type: Review

References (68)

1. Phylatou LA, Darrah C, Wood MJA (1998) Ribozyme-mediated trans-splicing of a trinucleotide repeat. Nat Genet 18:378-381
2. Lan N, Howrey RP, Lee SW, Smith CA, Sullenger BA (1998) Ribozyme-mediated repair of sickle β-globin mRNAs in erythrocyte precursors. Science 280:1593-1595
3. Tekur S, Ho SM (2002) Ribozyme-mediated downregulation of human metallothionein II (a) induces apoptosis in human prostate and ovarian cancer cell lines. Mol Carcinog 33:44-55
4. Long MB, Sullenger BA (1999) Evaluating group I intron catalytic efficiency in mammalian cells. Mol Cell Biol 19:6479-6487
5. Wadkins TS, Been MD (2002) Ribozyme activity in the genomic and antigenomic RNA strands of hepatitis delta virus. Cell Mol Life Sci 59:112-125
6. Sierakowska H, Gorman L, Kang SH, Kole R (2000) Antisense oligonucleotides and RNAs as modulators of pre-mRNA splicing. Methods Enzymol 313:506-521
7. Heintges T, Encke J, zu Putlitz J, Wands JR (2001) Inhibition of hepatitis C virus NS3 function by antisense oligodeoxynucleotides and protease inhibitor. J Med Virol 65:671-680
8. Song LY, Ahkong QF, Rong Q, Wang Z, Ansell S, Hope MJ, Mui B (2002) Characterization of the inhibitory effect of PEG-lipid conjugates on the intracellular delivery of plasmid and antisense DNA mediated by cationic lipid liposomes. Biochim Biophys Acta 1558:1-13
9. Kintsurashvili E, Gavras I, Johns C, Gavras H (2001) Effects of antisense oligodeoxynucleotide targeting of the alpha (2B)-adrenergic receptor messenger RNA in the central nervous system. Hypertension 38:1075-1080
10. Sugiyo S, Yonehara N, Appenteng K, Nokubi T, Shigenaga Y, Takemura M (2001) Effects of intrathecal c-fos antisense oligodeoxynucleotide on adjuvant-induced thermal hyperalgesia. Exp Brain Res 140:198-205
11. Rice MC, Czymmek K, Kmiec EB (2001) The potential of 1nucleic acid repair in functional genomics. Nat Biotechnol 19:321-326
12. Bailey C, Weeks DL (2000) Understanding oligonucleotide-mediated inhibition of gene expression in Xenopus laevis oocytes. Nucleic Acids Res 28:1154-1161
13. Cooney M, Czernuszewicz G, Postel EH, Flint SJ, Hogan ME (1988) Site-specific oligonucleotide binding represses transcription of human c-myc gene in vitro. Science 241:456-456
14. Catapano CV, McGuffie EM, Pacheco D, Carbone GM (2000) Inhibition of gene expression and cell proliferation by triple helix-forming oligonucleotides directed to the c-myc gene. Biochemistry 39:5126-5138
15. Shen C, Buck A, Mehrke G, Polat B, Gross H, Bachem M, Reske S (2001) Triplex forming oligonucleotide targeted to 3'UTR downregulates the expression of the bcl-2 proto-oncogene in HeLa cells. Nucleic Acids Res 29:622-628
16. Cheng B, Fournier RL, Relue PA, Schisler J (2001) An experimental and theoretical study of the inhibition of Escherichia coli lac operon gene expression by antigene oligonucleotides. Biotechnol Bioeng 74:220-229
17. Faria M, Wood CD, Perrouault L, Nelson JS, Winter A, White MR, Helene C, Giovannangeli C (2000) Targeted inhibition of transcription elongation in cells mediated by triplex-forming oligonucleotides. Proc Natl Acad Sci USA 97:3862-3867
18. Igoucheva O, Yoon K (2000) Targeted single-base correction by RNA-DNA oligonucleotides. Human Gene Ther 11:2307-2312
19. Cole-Strauss A, Gamper H, Holloman WK, Munoz M, Cheng N, Kmiec EB (1999) Targeted gene repair directed by the chimeric RNA/DNA oligonucleotide in a mammalian cell-free extract. Nucleic Acids Res 27:1323-1330
20. Mekeel KL, Tang W, Kachnic LA, Luo CM, DeFrank JS, Powell SN (1997) Inactivation of p53 results in high rates of homologous recombination. Oncogene 14:1847-1857
21. Gamper HB Jr, Cole-Strauss A, Metz R, Parekh H, Kumar R, Kmiec EB (2000) A plausible mechanism for gene correction by chimeric oligonucleotides. Biochemistry 39:5808-5816
22. Igoucheva O, Alexeev V, Yoon K (2001) Targeted gene correction by small single-stranded oligonucleotide in mammalian cells. Gene Ther 8:391-399
23. Gamper HB, Parekh H, Rice MC, Bruner M, Youkey H, Kmiec EB (2000) The DNA strand of chimeric RNA/DNA oligonucleotides can direct gene repair/conversion activity in mammalian and plant cell-free extracts. Nucleic Acids Res 28:4332-4339
24. Kmiec EB, Johnson C, May GD (2001) Chloroplast lysates support directed mutagenesis via modified DNA and chimeric RNA/DNA oligonucleotides. Plant J 27:267-274
25. Liu L, Rice MC, Kmiec EB (2001) In vivo gene repair of point and frameshift mutations directed by chimeric RNA/DNA oligonucleotides and modified single-stranded oligonucleotides. Nucleic Acids Res 29:4238-4250
26. Arimondo PB, Moreau P, Boutorine A, Bailly C, Prudhomme M, Sun JS, Garestier T, Helene C (2000) Recognition and cleavage of DNA by rebeccamycin- or benzopyridoquinoxaline conjugated of triple helix-forming oligonucleotides. Bioorg Med Chem 8:777-784
27. Torigoe H, Hari Y, Sekiguchi M, Obika S, Imanishi T (2001) 2′-O 4′-C-Methylene bridged nucleic acid modification promotes pyrimidine motif triplex DNA formation at physiological pH: Thermodynamic and kinetic studies. J Biol Chem 276:2354-2360
28. Casey BP, Glazer PM (2001) Gene targeting via triple-helix formation. Prog Nucleic Acid Res Mol Biol 67:163-192
29. Takasugi M, Guendouz A, Chassignol M, Decout JL, Lhomme J, Thuong NT, Helene C (1991) Sequence-specific photoinduced cross-linking of two strands of double-helical DNA by a psoralen covalently linked to a triple helix-forming oligonucleotide. Proc Natl Acad Sci USA 88:5602-5606
30. Havre PA, Gunther EJ, Gasparro FP, Glazer PM (1993) Targeted mutagenesis of DNA using triple helix-forming oligonucleotides linked to psoralen. Proc Natl Acad Sci USA 90:7879-7883
31. Wang G, Levy DD, Seidman MM, Glazer PM (1995) Targeted mutagenesis in mammalian cells mediated by intracellular triple helix formation. Mol Cell Biol 15:1759-1768
32. Wang G, Seidman MM, Glazer PM (1996) Mutagenesis in mammalian cells induced by triple helix formation and transcription-coupled repair. Science 271:802-805
33. Majumdar A, Khorlin A, Dyatkina N, Lin FL, Powell J, Liu J, Fei Z, Khripine Y, Watanabe KA, George J, Glazer PM, Seidman MM (1998) Targeted gene knockout mediated by triple helix forming oligonucleotides. Nat Genet 20:212-214
34. Vasquez KM, Wang G, Havre PA, Glazer PM (1999) Chromosomal mutations induced by triplex-forming oligonucleptides in mammalian cells. Nucleic Acids Res 27:1176-1181
35. Barre FX, Ait-Si-Ali S, Giovannangeli C, Luis R, Robin P, Pritchard LL, Helene C, Harel-Bellan A (1999) Unambigous demonstration of triple-helix-directed gene modification. Proc Natl Acad Sci USA 97:3084-3088
36. Chan PP, Lin M, Faruqi AF, Powell J, Seidman MM, Glazer PM (1999) Targeted correction of an episomal gene in mammalian cells by a short DNA fragment tethered to a triplex-forming. J Biol Chem 274:11541-11548
37. Culver KW, Hsieh WT, Huyen Y, Chen V, Liu J, Khripine Y, Khorlin A (1999) Correction of chromosomal point mutation in human cells with bifunctional oligonucleotides. Nat Biotechnol 17:989-993
38. Vasquez KM, Narayanan L, Glazer PM (2000) Specific mutations induced by triplex-forming oligonucleotides in mice. Science 290 530-533
39. Yoon K, Cole-Strauss A, Kmiec EB (1996) Targeted gene correction of episomal DNA in mammalian cells mediated by a chimeric RNA. DNA oligonucleotide. Proc Natl Acad Sci USA 93:2071-2076
40. Cole-Strauss A, Yoon K, Xiang Y, Byrne BC, Rice MC, Gryn J, Holloman WK, Kmiec EB (1996) Correction of the mutation responsible for sickle cell anemia by an RNA-DNA oligonucleotide. Science 273 1386-1389
41. Kren BT, Cole-Strauss A, Kmiec EB, Steer CJ (1997) Targeted nucleotide exchange in the alkaline phosphatase gene of HuH-7 cells mediated by a chimeric RNA/DNA oligonucleotide. Hepatology 25:1462-1468
42. Santana E, Peritz AE, Iyer S, Uitto J, Yoon K (1998) Different frequency of gene targeting events by the RNA-DNA oligonucleotide among epithelial cells. J Invest Dermatol 111:1172-1177
43. Xiang Y, Cole-Strauss A, Yoon K, Gryn J, Kmiec EB (1997) Targeted gene conversion in a mammalian CD34+-enriched cell population using a chimeric RNA/DNA oligonucleotide. J Mol Med 75:829-835
44. Alexeev V, Yoon K (1998) Stable and inheritable changes in genotype and phenotype of albino melanocytes induced by an RNA-DNA oligonucleotide. Nat Biotechnol 16:1343-1346
45. Li ZH, Liu DP, Yin WX, Guo ZC, Liang CC (2001) Targeted correction of point mutations of β-thalassemia and targeted mutagenesis of nucleotide associated with HPFH by RNA/DNA oligonucleotides: Potential for β-thalassemia gene therapy. Blood Cells Mol Dis 27:1-9
46. Kren BT, Bandyopadhyay P, Steer CJ (1998) In vivo site-directed mutagenesis of the factor IX gene by chimeric RNA/DNA oligonucleotides. Nat Med 4:285-290
47. Kren BT, Parashar B, Bandyopadhyay P, Chowdhury NR, Chowdhury JR, Steer CJ (1999) Correction of the UDP-glucuronosyltransferase gene defect in the gunn rat model of crigler-najjar syndrome type I with a chimeric oligonucleotide. Proc Natl Acad Sci USA 96:10349-10354
48. Beetham PR, Kipp PB, Sawycky XL, Arntzen CJ, May GD (1999) A tool for functional plant genomics: Chimeric RNA/DNA oligonucleotides cause in vivo gene-specific mutations. Proc Natl Acad Sci USA 96:8774-8778
49. Alexeev V, Igoucheva O, Domashenko A, Cotsarelis G, Yoon K (2000) Localized in vivo genotypic and phenotypic correction of the albino mutation in skin by RNA-DNA oligonucleotide. Nat Biotechnol 18:43-47
50. Rando TA, Disatnik MH, Zhou LZ (2000) Rescue of dystrophin expression in mdx mouse muscle by RNA/DNA oligonucleotides. Proc Natl Acad Sci USA 97:5363-5368
51. Bartlett RJ, Stockinger S, Denis MM, Bartlett WT, Inverardi L, Le TT, thi Man N, Morris GE, Bogan DJ, Metcalf-Bogan J, Kornegay JN (2000) In vivo targeted repair of a point mutation in the canine dystrophin gene by a chimeric RNA/DNA oligonucleotide. Nat Biotechnol 18:615-622
52. Chen Z, Felsheim R, Wong P, Augustin LB, Metz R, Kren BT, Steer CJ (2001) Mitochondria isolated from liver contain the essential factors required for RNA/DNA oligonucleotide-targeted gene repair. Biochem Biophys Res Commun 285:188-194
53. Luo D, Saltzman WM (2000) Synthetic DNA delivery systems. Nat Biotechnol 18:33-37
54. Chen QR, Zhang L, Stass SA, Mixson AJ (2000) CO-polymer of histidine and lysine markedly enchances transfection efficiency of liposomes. Gene Ther 7:1698-1705
55. Chan CK, Senden T, Jans DA (2000) Supramolecular structure and nuclear targeting efficiency determine the enchancement of transfection by modified polylysines. Gene Ther 7:1690-1697
56. Igoucheva O, Peritz AE, Levy D, Yoon K (1999) A sequence-specific gene correction by an RNA-DNA oligonucleotide in mammalian cells characterized by transfection and nuclear extract using a lacZ shuttle system. Gene Ther 6:1960-1971
57. Rice MC, May GD, Kipp PB, Parekh H, Kmiec EB (2000) Genetic repair of mutations in plant cell-free extracts directed by specific chimeric oligonucleotides. Plant Physiol 123:427-438
58. Wu XS, Liu DP, Liang CC (2001) Prospects of chimeric RNA-DNA oligonucleotides in gene therapy. J Biomed Sci 8:439-445
59. Rice MC, Bruner M, Czymmek K, Kmiec EB (2001) In vitro and in vivo nucleotide exchange directed by chimeric RNA/DNA oligonucleotides in Saccharomyces cerevisae. Mol Microbiol 40:857-868
60. Steege G van der, Schuilenga-Hut PH, Buys CH, Scheffer H, Pas HH, Jonkman MF (2001) Persistent failures in gene therapy. Nat Biotechnol 19:305-306
61. Puri N, Majumdar A, Cuenoud B, Natt F, Martin P, Boyd A, Miller PS, Seidman MM (2001) Targeted gene knockout by 2′-O-aminoethyl modified triplex forming oligonucleotides. J Biol Chem 276:28991-28998
62. Torigoe H (2001) Thermodynamic and kinetic effects of N3′P5′ phosphoramidate modification on pyrimidine motif triplex DNA formation. Biochemistry 40:1063-1069
63. Khan A, Sommer W, Fuxe K, Akhtar S (2000) Site-specific administration of antisense oligonucleotides using biodegradable polymer microspheres provides sustained delivery and improved subcellular biodistribution in the neostriatum of the rat brain. J Drug Target 8:319-334
64. Zhang YM, Liu N, Zhu ZH, Rusckowski M, Hnatowich DJ (2000) Influence of different chelators (HYNIC, MAG3 and DTPA) on tumor cell accumulation and mouse biodistribution of technetium-99m labeled to antisense DNA. Eur J Nucl Med 27:1700-1707
65. Faruqi AF, Datta HJ, Carroll D, Seidman MM, Glazer PM (2000) Triple-helix formation induces recombination in mammalian cells via a nucleotide excision repair-dependent pathway. Mol Cell Biol 20:990-1000
66. Datta HJ, Chan PP, Vasquez KM, Gupta RC, Glazer PM (2001) Triplex-induced recombination in human cell-free extracts. Dependence on XPA and HsRad51. J Biol Chem 276:18018-18023
67. Luo Z, Macris MA, Faruqi AF, Glazer PM (2000) High-frequency intrachromosomal gene conversion induced by triplex-forming oligonucleotides microinjected into mouse cells. Proc Natl Acad Sci USA 97:9003-9008
68. Tagalakis AD, Graham IR, Riddell DR, Dickson JG, Owen JS (2001) Gene correction of the apolipoprotein (apo) E2 phenotype to wild-type apoE3 by in situ chimeraplasty. J Biol Chem 276:13226-13230